JP2009509545A5 - - Google Patents

Download PDF

Info

Publication number
JP2009509545A5
JP2009509545A5 JP2008533695A JP2008533695A JP2009509545A5 JP 2009509545 A5 JP2009509545 A5 JP 2009509545A5 JP 2008533695 A JP2008533695 A JP 2008533695A JP 2008533695 A JP2008533695 A JP 2008533695A JP 2009509545 A5 JP2009509545 A5 JP 2009509545A5
Authority
JP
Japan
Prior art keywords
activity
biological
treatment
sample
biosensor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008533695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009509545A (ja
JP5346583B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/038175 external-priority patent/WO2007038756A2/en
Publication of JP2009509545A publication Critical patent/JP2009509545A/ja
Publication of JP2009509545A5 publication Critical patent/JP2009509545A5/ja
Application granted granted Critical
Publication of JP5346583B2 publication Critical patent/JP5346583B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008533695A 2005-09-28 2006-09-27 生物検体の生物活性を解析するための方法及び構築物、並びに生物の状態を測定するための方法及び構築物 Expired - Fee Related JP5346583B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72186005P 2005-09-28 2005-09-28
US60/721,860 2005-09-28
PCT/US2006/038175 WO2007038756A2 (en) 2005-09-28 2006-09-27 Methods and constructs for analyzing biological activities of biological specimens and determining states of organism

Publications (3)

Publication Number Publication Date
JP2009509545A JP2009509545A (ja) 2009-03-12
JP2009509545A5 true JP2009509545A5 (enExample) 2009-11-05
JP5346583B2 JP5346583B2 (ja) 2013-11-20

Family

ID=37900495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008533695A Expired - Fee Related JP5346583B2 (ja) 2005-09-28 2006-09-27 生物検体の生物活性を解析するための方法及び構築物、並びに生物の状態を測定するための方法及び構築物

Country Status (5)

Country Link
US (1) US20100009348A1 (enExample)
EP (1) EP1945795B1 (enExample)
JP (1) JP5346583B2 (enExample)
CA (1) CA2623795C (enExample)
WO (1) WO2007038756A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2430579A2 (en) * 2009-05-11 2012-03-21 Koninklijke Philips Electronics N.V. Device and method for comparing molecular signatures
GB201002130D0 (en) * 2010-02-10 2010-03-31 Tmri Ltd Cell based bioassay
US20120245048A1 (en) * 2011-03-25 2012-09-27 Institute For Systems Biology Cellular response assay for biofluid biomarker discovery and detection
CN103930566B (zh) * 2011-09-08 2018-01-26 埃塔格尼公司 用于测定水中生物污染物的系统和方法
US20140323341A1 (en) * 2011-09-08 2014-10-30 Attagene, Inc. Systems and methods for assessment of biosimilarity
WO2014121104A1 (en) * 2013-01-31 2014-08-07 The Regents Of The University Of California Pooled genetic perturbation effects
JP2021078370A (ja) * 2019-11-15 2021-05-27 国立大学法人大阪大学 全身性エリトマトーデスの治療薬に対するコンパニオン診断薬
EP4399523A4 (en) * 2021-09-07 2025-02-19 Mayo Foundation for Medical Education and Research Methods and materials for determining pgc target dosage

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5625048A (en) * 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5928868A (en) * 1996-04-26 1999-07-27 Massachusetts Institute Of Technology Three hybrid screening assay
EP1141359B1 (en) * 1998-12-17 2006-10-04 Xenogen Corporation Non-invasive evaluation of physiological response in a mammal
GB2355791B (en) * 1999-10-28 2004-10-20 Molecular Light Tech Res Ltd Detection of mRNA expression using chemiluminescent labelled probes
US6867348B1 (en) * 1999-12-16 2005-03-15 Xenogen Corporation Methods and compositions for screening for angiogenesis modulating compounds
CA2327581A1 (en) * 2000-12-27 2002-06-27 Yves Blais Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules
US20020177218A1 (en) * 2001-03-30 2002-11-28 Yu Fang Methods of detecting multiple DNA binding protein and DNA interactions in a sample, and devices, systems and kits for practicing the same
AU2002314927A1 (en) * 2001-06-06 2002-12-16 Cogent Neuroscience, Inc. Nucleic acid regulatory sequences and uses therefor
US20030143547A1 (en) * 2002-01-24 2003-07-31 Xianqiang Li Method for identifying multiple activated transcription factors
US20030148287A1 (en) * 2002-01-24 2003-08-07 Xianqiang Li Libraries and kits for detecting transcription factor activity
DE10211063A1 (de) * 2002-03-13 2003-10-09 Axaron Bioscience Ag Neue Verfahren zur Detektion und Analyse von Protein-Interaktionen in vivo
WO2004094653A2 (en) * 2003-04-22 2004-11-04 Irm Llc Differential tag length analysis of cell proliferation
US20050181354A1 (en) * 2004-02-18 2005-08-18 Estep Preston W.Iii Methods of assaying physiological states
JP5301160B2 (ja) * 2004-11-10 2013-09-25 アッタゲネ インコーポレーテッド レポーター配列の集団及びそれらの使用方法

Similar Documents

Publication Publication Date Title
Yoshida et al. Induction of IL-8, MCP-1, and bFGF by TNF-α in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation
Namburi et al. A circuit mechanism for differentiating positive and negative associations
Yang et al. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor
Yiin et al. Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity
Ruiz‐Sauri et al. Glia to neuron ratio in the posterior aspect of the human spinal cord at thoracic segments relevant to spinal cord stimulation
Hou et al. PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets
US20170058349A1 (en) Methods for managing care of patients predisposed to progressive mitral valve diseases
PT1198585E (pt) Processo para caracterizar uma condição biológica usando perfis calibrados da expressão de genes
JPH029391A (ja) 大食細胞誘導炎症性神経細胞
JP2009509545A5 (enExample)
Nordbø et al. Transcriptomic analysis reveals partial epithelial–mesenchymal transition and inflammation as common pathogenic mechanisms in hypertensive nephrosclerosis and Type 2 diabetic nephropathy
Carta et al. Neurodynamic treatment promotes mechanical pain modulation in sensory neurons and nerve regeneration in rats
Abouhashem et al. The prolonged terminal phase of human life induces survival response in the skin transcriptome
Spencer et al. Research techniques made simple: Parabiosis to elucidate humoral factors in skin biology
Lee et al. Promotion of neurite outgrowth and axon guidance in spiral ganglion cells by netrin-1
Kwaśniewska et al. Noradrenergic components of locomotor recovery induced by intraspinal grafting of the embryonic brainstem in adult paraplegic rats
Oh et al. Gene expression and plasticity in the rat auditory cortex after bilateral cochlear ablation
Yang et al. In search of underlying mechanisms and potential drugs of melphalan-induced vascular toxicity through retinal endothelial cells using bioinformatics approach
Klion et al. Advances in eosinophilic diseases in 2018
JP2009509545A (ja) 生物検体の生物活性を解析するための方法及び構築物、並びに生物の状態を測定するための方法及び構築物
CN109781998A (zh) Hmgb1基因或蛋白表达在评估芪归银治疗肺炎效果中的用途
Wohlschlaeger et al. Cardiomyocyte survivin protein expression is associated with cell size and DNA content in the failing human heart and is reversibly regulated after ventricular unloading
CN115584345A (zh) 确定肿瘤电场治疗参数的方法
CN115684605A (zh) GAK蛋白和/或GAK mRNA作为帕金森诊断生物标记物的用途
Labelle et al. Effects of ophthalmic disease on concentrations of plasma fibrinogen and serum amyloid A in the horse